Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Unaudited financial (Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Ltd has informed BSE that its Board of Directors will meet on Friday, November 14, 2025. The key agenda item is to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half year ended September 30, 2025, along with the Limited Review Report by the Statutory Auditors. The trading window for designated insiders has been closed since October 1, 2025, and will remain closed until 48 hours after the results are made public. No actual financial numbers have been disclosed yet in this filing — they will be released post the board meeting.
This is a routine pre-results intimation and not an earnings announcement itself. Shareholders should watch for the actual Q2/H1 FY26 results on or after November 14, 2025, which could move the stock depending on the numbers versus expectations. Until then, the insider trading window closure signals that management and insiders are restricted from trading ahead of the disclosure.